Examples of using Bendamustine in English and their translations into German
{-}
-
Colloquial
-
Official
-
Ecclesiastic
-
Medicine
-
Financial
-
Ecclesiastic
-
Political
-
Computer
-
Programming
-
Official/political
-
Political
Arzerra in combination with chlorambucil or bendamustine is indicated for the treatment of patients with CLL who have not received prior therapy
Bendamustine was given intravenously on Days 1
IMBRUVICA as a single agent or in combination with bendamustine and rituximab(BR) is indicated for the treatment of adult patients with CLL who have received at least one prior therapy.
The results of this study demonstrated that Arzerra in combination with bendamustine is an effective therapy providing an ORR of 95%(95% CI:
In study GAO4753g, patients in the bendamustine(B) arm received 6 months of induction treatment only,
Continue phase 3 study evaluating tafasitamab plus bendamustine in r/r DLBCL.
To evaluate the efficacy of Bendamustine plus GA101(BG) in patients with relapsed CLL.
Effectiveness of Bendamustine vs. CHOP compared in Phase III trial,
Progressive/relapsed CLL after treatment with regimens not containing purine analogs e.g. Chlorambucil, Bendamustine.
Then with Bendamustine and Rituxan for 4 months which was discontinued when I developed pneumonia….
In addition, we are currently evaluating MOR208 in combination with bendamustine in our phase 3 B-MIND trial.
Patients with relapsed or refractory CLL with max 3 prior regimens in case of pretreatment with bendamustine: PR≥ 6 month.
More CLL2M Multicentre phase II trial of Bendamustine in combination with rituximab for patients with previously untreated
B-MIND: Continue the pivotal phase 3 study evaluating MOR208 plus bendamustine versus rituximab plus bendamustine in r/r DLBCL.
In the GREEN safety study, data from a subgroup analysis showed there were no unexpected safety signals when Gazyva/Gazyvaro was combined with bendamustine.
when treated with Gazyva(obinutuzumab) plus bendamustine followed by Gazyva alone, compared to bendamustine alone.
B-MIND compares the efficacy of tafasitamab(MOR208) plus bendamustine versus rituximab plus bendamustine in patients with relapsed
The most common Grade 3-4 adverse events that occurred more often(at least 2 percent or greater) in those receiving the Gazyva/Gazyvaro plus bendamustine regimen compared to those receiving bendamustine alone were low white blood cell count neutropenia;
CVP or bendamustine) followed by Gazyva/Gazyvaro alone,
CVP or bendamustine) followed by Gazyva/Gazyvaro alone,